F. Yıldız and B. Öksüzoğlu, “Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer”, J Surg Med, vol. 4, no. 6, pp. 443–446, Jun. 2020.